NHS Genomics Strategy launched today at #NHSGenomics2022 by @AmandaPritchard It sets out our ambitions over the next 5-10 years to harness the potential of genomics to transform patient care. https://www.england.nhs.uk/genomics/genomics-strategy/
Monday 25th October saw the launch of the NHS Cancer Quality of Life Survey data dashboard. The survey is for people in England who have been diagnosed with cancer. From 2020, people who have had a breast, prostate or colorectal (bowel) cancer diagnosis are being...
Genomics : PART ONE : 100,000 Genomes Project – and beyond! In late 2012, the then Prime Minister, David Cameron, announced the 100,000 Genomes Project. Its four main aims were; to enable new scientific discovery and medical insights to bring benefit to...
21st APRIL NICE APPROVES AVELUMAB Neuroendocrine Cancer UK is delighted to share with you NICE’s approval of Avelumab as a first line therapy option in metastatic MCC. Avelumab is now recommended as an option for treating metastatic Merkel cell carcinoma in adults...
Public Health England (PHE), NHS England and NHS Improvement (NHSE&I) have launched a nationwide Cancer Quality of Life Survey to find out how quality of life may have changed for people diagnosed with cancer. The information collected from the survey will help us...